Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $105.2200 (-2.81%) ($104.9000 - $108.7000) on Wed. Aug. 26, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.83% (three month average) | RSI | 34 | Latest Price | $105.2200(-2.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.7% a day on average for past five trading days. | Weekly Trend | LGND declines -2.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -1.415% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-15%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.415% (StdDev 2.83%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $114.48 | 5 Day Moving Average | $109.65(-4.04%) | 10 Day Moving Average | $111.98(-6.04%) | 20 Day Moving Average | $114.48(-8.09%) | To recent high | -17% | To recent low | 4.4% | Market Cap | $1.691b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |